---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-22-000051"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2022-09-13T23:59:59+00:00"
generated_at: "2026-06-23T09:59:59.458654+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioRestorative exchanges preferred shares with Auctus, replaces auditor after Friedman/Marcum merger

## Summary
- Issued 1,543,158 Series B preferred shares to Auctus Fund in exchange for same number of Series A shares on Sept 8, 2022.
- Series B preferred stock raises beneficial ownership limitation to 9.99% of common stock (up from 4.99% for Series A).
- Audit Committee dismissed Friedman LLP and engaged Marcum LLP as independent auditor on Sept 13, 2022, following Friedman's combination with Marcum.
- Friedman's reports for FY2020 and FY2021 were unqualified with no disagreements or reportable events.

## SEC filing metadata
- accession: 0001021771-22-000051
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2022-09-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 4.01, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177122000051/0001021771-22-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177122000051/form8kdtd090822.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-22-000051
- JSON: https://secwatch.observer/filing/0001021771-22-000051.json
- Plain text: https://secwatch.observer/filing/0001021771-22-000051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.